Recent Advances in Neuromyelitis Optica Spectrum Disorder: Pathogenesis, Mechanisms and Potential Treatments

Neuromyelitis optica spectrum disorder (NMOSD) is an acute or subacute demyelinating disease that affects mainly the optic nerve and spinal cord. A major proportion of NMOSD cases have a relationship with autoimmunity to aquaporin 4 (AQP4) found on the central nervous system. NMOSD can occur repeate...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Current pharmaceutical design Ročník 28; číslo 4; s. 272
Hlavní autori: Du, Yi, Li, Kaijun, Liu, Wei, Song, Ruitong, Luo, Meifeng, He, Jianfeng, Xu, Xiaoyu, Qu, Xiaosheng
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United Arab Emirates 01.01.2022
Predmet:
Aquaporin 4
Autoantibodies
Humans
Neuromyelitis Optica - diagnosis
Neuromyelitis Optica - drug therapy
Spinal Cord
pathogenesis
AQP4
Devic’s disease
autoimmunity
therapy
NMOSD
ISSN:1873-4286, 1873-4286
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Neuromyelitis optica spectrum disorder (NMOSD) is an acute or subacute demyelinating disease that affects mainly the optic nerve and spinal cord. A major proportion of NMOSD cases have a relationship with autoimmunity to aquaporin 4 (AQP4) found on the central nervous system. NMOSD can occur repeatedly, causing symptoms such as decreased vision and weakness of limbs. The main goal of the current therapy is to relieve acute symptoms and prevent recurrence of the disease. Without timely and appropriate treatment, the recurrence and disability rates are high. In the present work, we review recent advances in the diagnosis and treatment of patients with NMOSD, as well as the pathogenesis and mechanisms of AQP4-IgG-seropositive NMOSD.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1873-4286
1873-4286
DOI:10.2174/1381612827666210329101335